Clinical Cardiology 1501 - Clinical Cardiology Alert - Jan 01, 2011

Target Audience:

This activity is intended for the cardiologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Cardiology
University of California
San Francisco

Editorial Board Members
Andrew J. Boyle, MBBS, PhD
Assistant Professor of Medicine
Interventional Cardiology
University of California
San Francisco

John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia
Charlottesville

Peer Reviewer
Ethan Weiss, MD
Assistant Professor of Medicine
Division of Cardiology and CVRI
University of California, San Francisco

Subjects:

  • New Study Supports More Appropriate Blood Pressure Levels for Post-ACS Patients
  • Finding the Value of High-sensitivity Troponin Assays
  • Omeprazole and Clopidogrel — Is There a Clinically Meaningful Interaction?
  • Colchicine Prevents Post-pericardiotomy Syndrome
  • Study Identifies Incidence and Origin of PEA

Objectives:

  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert’s physician editor, Michael H. Crawford, MD, is on the speaker’s bureau for Pfizer. Editorial board member Andrew J. Boyle, MBBS, PhD, and peer reviewer, Ethan Weiss, MD, reports no consultant, stockholder, speaker’s bureau, or other financial relationship with any company related to this field of study. Editorial board member John P. DiMarco, MD, PhD receives grant/research support from Medtronic, is a consultant for Medtronic, Novartis, and St. Jude, and is a speaker for Boston Scientific.

Copyright 2011 AHC Media. All rights reserved.